News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research> UBS Lowers EPS Forecasts for WUXI BIO (02269.HK) for This and Next Year, Slightly Reduces TP to HKD49.3
UBS research report indicated that WUXI BIO (02269.HK) met expectations with its performance in the second half of last year, with revenue increasing by 17.2% year-on-year to RMB11...
Reset
Send
The window will close in 5 seconds
<Research> UBS Lowers EPS Forecasts for WUXI BIO (02269.HK) for This and Next Year, Slightly Reduces TP to HKD49.3
Close
Recommend
9
Positive
8
Negative
12
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

UBS research report indicated that WUXI BIO (02269.HK)  +0.120 (+0.344%)    Short selling $282.70M; Ratio 73.681%   met expectations with its performance in the second half of last year, with revenue increasing by 17.2% year-on-year to RMB11.8 billion (same below), and profit attributable to shareholders rising by 38.3% year-on-year to RMB2.6 billion. The gross profit margin improved by 5 ppts to 46%, mainly driven by enhanced operational efficiency, increased licensing revenue, and higher facility utilization.

The report mentioned that WUXI BIO's management expects a revenue growth of 13% to 17% year-on-year by 2026. UBS estimates that this high growth aligns with expectations, but considering potential exchange rate impacts and the performance in the second half of 2025, UBS has lowered the group's EPS forecasts for this and next year by 4% to 5%. The target price has been slightly reduced from HKD51.6 to HKD49.3, corresponding to a forecasted P/E ratio of 33x and 27x for this and next year, respectively, maintaining a "Buy" rating. (hc/w)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.